Anest. intenziv. Med. 2016;27(4):243-251

Metformin-associated lactic acidosisIntesive Care Medicine - Case Report

T. Karvunidis*, M. Harazim, J. Raděj, I. Novák, J. Horák, M. Matějovič
I. interní klinika, Fakultní nemocnice Plzeň a Lékařská fakulta Plzeň, Univerzita Karlova v Praze

This review summarizes the issue of metformin-associated lactic acidosis based on three case reports of patients with a significant haemodynamic alteration - severe circulatory shock associated with lactic acidosis.

Keywords: metformin; lactic acidosis; circulatory shock; intensive care

Received: January 23, 2016; Accepted: June 2, 2016; Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karvunidis T, Harazim M, Raděj J, Novák I, Horák J, Matějovič M. Metformin-associated lactic acidosis. Anest. intenziv. Med. 2016;27(4):243-251.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Inzucchi, S. E., Bergenstal, R. M., Buse, J. M. et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD). Diabetes Care, 2012, 6, p. 1364-1379. Go to original source... Go to PubMed...
    2. Lamanna, C., Monami, M., Marchionni, N., Mannucci, E. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Diabetes Obes. Metab., 2011, 3, p. 221-228. Go to original source... Go to PubMed...
    3. Pernicova, I., Korbontis, M. Metformin - mode of action and clinical implications for diabetes and cancer. Nat. Rev. Endocrinol., 2014, 3, p. 143-156. Go to original source... Go to PubMed...
    4. Glueck, C. J., Fontaine, R. N., Wang, P. et al. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism, 2001, 7, p. 856-861. Go to original source... Go to PubMed...
    5. Salpeter, S. R., Bucklea, N. S., Kahn, J. A., Salpeter, E. E. Meta-analysis: metformin treatment in persons a» risk for diabetes mellitus. Am. J. Med., 2008, 2, p. 149-157. Go to original source... Go to PubMed...
    6. ADVANCE Collaborative Group. Intensive blood control and vascular Outcomes in patients with type 2 diabetes. N. Engl. J. Med., 2008, 24, p. 2560-2572. Go to original source... Go to PubMed...
    7. ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular Outcomes. N. Engl. J. Med., 2011, 9, p. 818-828. Go to original source... Go to PubMed...
    8. Libby, G., Donnelly, L. A., Donnan, P. T. et al. New users of metformin are a» low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care, 2009, 9, p. 1620-1625. Go to original source... Go to PubMed...
    9. Landman, G. W., Kleefstra, N., van Hateren, K. J. et al. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care, 2010, 2, p. 322-326. Go to original source... Go to PubMed...
    10. Graha, G. G., Punt, J., Arora, M. et al. Clinical pharmacokine-tics of metformin. Clin. Pharmacokinet., 2011, 2, p. 81-98. Go to original source... Go to PubMed...
    11. Duong, J. K., Furlong, T. J., Roberts, D. M. et al. The role of metformin in metformin-associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis. Drug Saf., 2013, 9, p. 733-746. Go to original source... Go to PubMed...
    12. de Jager, J., Kooy, A., Lehert, P. et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ, 2010, 340, p. 2181-2187. Go to original source... Go to PubMed...
    13. Andrzejewski, S., Gravel, S-P., Pollak, M., St-Pierre, J. Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab., 2014, 2. Go to original source... Go to PubMed...
    14. Wheaton, W. W., Weinberg, S. E., Chandel, N. S. et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumourgenesis. eLife, 2014, 3. Go to original source...
    15. Bridges, H. R., Jones, A. J., Pollak, M. N., Hirst, J. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J, 2014, 3, p. 475-487. Go to original source... Go to PubMed...
    16. Vecchio, S., Giampreti, A., Petrolini, V. M. et al. Metformin accumulation: lactic acidosis and high plasmatic metformin levels in retrospective case series of 66 patients on chronic therapy. Clin. Toxicol., 2014, 2, p. 129-135. Go to original source... Go to PubMed...
    17. Salpeter, S., Greyber, E., Pasternak, G., Salpeter, E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev, 2006, 1. Go to original source... Go to PubMed...
    18. Salpeter, S., Greyber, E., Pasternak, G., Salpeter, E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev, 2010, 4. Go to original source... Go to PubMed...
    19. Chang, C. T., Chen, Y. C., Fang, J. T., Huang, C. C. High anion gap metabolic acidosis in suicide: don't forget metformin intoxication - two patients' experiences. Ren Fail, 2012, 5, p. 671-675. Go to original source... Go to PubMed...
    20. Lalau, J. D., Lacroix, C., Compagnon, P. et al. Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care, 1995, 18, 6, p. 779-784. Go to original source... Go to PubMed...
    21. Lalau, J. D., Race, J. M. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentration. Drug Saf, 1999, 4, p. 377-384. Go to original source... Go to PubMed...
    22. DeFronzo, R., Fleming, G. A., Chen, K., Bicsak, T. A. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism, 2016, 2, p. 20-29. Go to original source... Go to PubMed...
    23. Kirpichnikov, D., McFarlane, S. I., Sowers, J. R. Metformin: an update. Ann. Intern. Med., 2002, 1, p. 25-33. Go to original source... Go to PubMed...
    24. Seidowsky, A., Nseir, S., Houdret, N., Fourrier, F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit. Care Med., 2009, 7, p. 2191-2196. Go to original source... Go to PubMed...
    25. Friesecke, S., Abel, P., Roser, M., Felix, S. B., Runge, S. Outcome of severe lactic acidosis associated with metformin accumulation. Crit. Care, 2010, 6, p. 226. Go to original source... Go to PubMed...
    26. Radej, J., Matejovic, M., Krouzecky, A. et al. How severe acidosis can a human survive? Successful hemofiltration use. Dial. Transplant., 2007, 11, p. 608-611. Go to original source...
    27. Hoste, E. A., Dhondt, A. Clinical review: use a renal replacement therapies in special groups of ICU patients. Crit. Care, 2012, 1, p. 201. Go to original source... Go to PubMed...
    28. Calello, D. P., Liu, K. D., Wiegand, T. J. et al. Extracorporeal treatment for metformin poisoning: systematic review and re-commendations from the extracorporeal treatments in poisoning workgroup. Crit. Care Med., 2015, 8, p. 1716-1730. Go to original source... Go to PubMed...
    29. Ronco, C., Ricci, Z., DeBacker, D et al. Renal replacement therapy in acute kidney injury: controversy and consensus. Crit. Care, 2015, 1, p. 146-156 Go to original source... Go to PubMed...
    30. Vinsonneau, C., Allain-Launay, E., Blayau, C. et al. Renal replacement therapy in adult and pediatric intensive care: recommendations by an expert panel from the SRLF with the SFAR, GFRUP and SFD. Ann. Intensive Care, 2015, 1, p. 58. Go to original source... Go to PubMed...
    31. Bai, M., Zhou, M., He, L. et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med., 2015, 12, p. 2098-2110. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.